instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone pain'. | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | PREDNISONE | DrugsGivenReaction | CC BY | 34120629 | 19,551,533 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cushing^s syndrome'. | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | CYCLOSPORINE, ETHINYL ESTRADIOL\LEVONORGESTREL, PREDNISONE | DrugsGivenReaction | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cushingoid'. | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | PREDNISONE | DrugsGivenReaction | CC BY | 34120629 | 19,551,533 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Menopausal symptoms'. | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | CYCLOSPORINE, ETHINYL ESTRADIOL\LEVONORGESTREL, PREDNISONE | DrugsGivenReaction | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteopenia'. | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | PREDNISONE | DrugsGivenReaction | CC BY | 34120629 | 19,551,533 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteoporosis'. | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | CYCLOSPORINE, ETHINYL ESTRADIOL\LEVONORGESTREL, PREDNISONE | DrugsGivenReaction | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
What was the administration route of drug 'ETHINYL ESTRADIOL\LEVONORGESTREL'? | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | Oral | DrugAdministrationRoute | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
What was the administration route of drug 'PREDNISONE'? | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | Oral | DrugAdministrationRoute | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
What was the outcome of reaction 'Adrenal insufficiency'? | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | Recovered | ReactionOutcome | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
What was the outcome of reaction 'Cushing^s syndrome'? | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | Recovered | ReactionOutcome | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
What was the outcome of reaction 'Menopausal symptoms'? | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | Recovering | ReactionOutcome | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
What was the outcome of reaction 'Osteoporosis'? | Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
BACKGROUND
Autoimmune progesterone dermatitis (APD) is a rare skin condition caused by sensitivity to high levels of progesterone secreted during the luteal phase of the menstrual cycle. This may be due to v... | Recovering | ReactionOutcome | CC BY | 34120629 | 19,596,476 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin.
Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropat... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34120651 | 20,330,750 | 2021-06-13 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin.
Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropat... | 2000 mg (milligrams). | DrugDosage | CC BY | 34120651 | 20,330,750 | 2021-06-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiocentric lymphoma'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,786,635 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus oesophagitis'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,786,635 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus associated lymphoproliferative disorder'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection reactivation'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34121006 | 20,786,635 | 2021-12-01 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
What was the outcome of reaction 'Angiocentric lymphoma'? | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | Recovered | ReactionOutcome | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
What was the outcome of reaction 'Epstein-Barr virus associated lymphoproliferative disorder'? | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | Recovered | ReactionOutcome | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
What was the outcome of reaction 'Epstein-Barr virus infection reactivation'? | High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less th... | Recovered | ReactionOutcome | CC BY-NC-ND | 34121006 | 20,773,822 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | AMLODIPINE BESYLATE, ASPIRIN, DOXAZOSIN MESYLATE, FOSINOPRIL, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE, METOPROLOL, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34121667 | 20,148,365 | 2021-06-01 |
What was the administration route of drug 'LEVOTHYROXINE'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34121667 | 19,486,432 | 2021-06-01 |
What was the administration route of drug 'ROSUVASTATIN'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34121667 | 20,148,365 | 2021-06-01 |
What was the dosage of drug 'ROSUVASTATIN CALCIUM'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | 40 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34121667 | 19,588,011 | 2021-06-01 |
What was the outcome of reaction 'Condition aggravated'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Recovering | ReactionOutcome | CC BY-NC-ND | 34121667 | 19,594,834 | 2021-06-01 |
What was the outcome of reaction 'Hyperparathyroidism'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Recovering | ReactionOutcome | CC BY-NC-ND | 34121667 | 19,594,834 | 2021-06-01 |
What was the outcome of reaction 'Metabolic acidosis'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Recovered | ReactionOutcome | CC BY-NC-ND | 34121667 | 20,148,365 | 2021-06-01 |
What was the outcome of reaction 'Treatment failure'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Recovered | ReactionOutcome | CC BY-NC-ND | 34121667 | 20,148,365 | 2021-06-01 |
What was the outcome of reaction 'Treatment noncompliance'? | Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a dail... | Recovered | ReactionOutcome | CC BY-NC-ND | 34121667 | 19,594,834 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aplasia'. | Recurrent aplastic anemia with donor-type aplasia: A rare occurrence in the Indian subcontinent.
Donor-type aplasia (DTA) is a condition where an individual continues to be aplastic even after a successful engraftment of a hematopoeitic stem cell transplant with a majority of donor type cells in the bone marrow. This e... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-SA | 34121669 | 20,854,323 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Recurrent aplastic anemia with donor-type aplasia: A rare occurrence in the Indian subcontinent.
Donor-type aplasia (DTA) is a condition where an individual continues to be aplastic even after a successful engraftment of a hematopoeitic stem cell transplant with a majority of donor type cells in the bone marrow. This e... | LOW DOSE | DrugDosageText | CC BY-NC-SA | 34121669 | 20,854,323 | 2021 |
What was the outcome of reaction 'Aplasia'? | Recurrent aplastic anemia with donor-type aplasia: A rare occurrence in the Indian subcontinent.
Donor-type aplasia (DTA) is a condition where an individual continues to be aplastic even after a successful engraftment of a hematopoeitic stem cell transplant with a majority of donor type cells in the bone marrow. This e... | Fatal | ReactionOutcome | CC BY-NC-SA | 34121669 | 20,854,323 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric ulcer'. | Unusual severe gastritis and gastric ulcers caused by pembrolizumab.
Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 34121670 | 19,534,573 | 2021-06-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated gastritis'. | Unusual severe gastritis and gastric ulcers caused by pembrolizumab.
Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 34121670 | 19,534,573 | 2021-06-11 |
What was the outcome of reaction 'Gastric ulcer'? | Unusual severe gastritis and gastric ulcers caused by pembrolizumab.
Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy... | Recovering | ReactionOutcome | CC BY-NC-SA | 34121670 | 19,534,573 | 2021-06-11 |
What was the outcome of reaction 'Immune-mediated gastritis'? | Unusual severe gastritis and gastric ulcers caused by pembrolizumab.
Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy... | Recovering | ReactionOutcome | CC BY-NC-SA | 34121670 | 19,534,573 | 2021-06-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chills'. | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | ALDESLEUKIN, MYCOPHENOLIC ACID, PREDNISONE, SIROLIMUS, TACROLIMUS | DrugsGivenReaction | CC BY | 34122442 | 20,113,605 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | MYCOPHENOLIC ACID, PREDNISONE, SIROLIMUS, TACROLIMUS | DrugsGivenReaction | CC BY | 34122442 | 20,068,020 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site pain'. | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | ALDESLEUKIN, MYCOPHENOLIC ACID, PREDNISONE, SIROLIMUS, TACROLIMUS | DrugsGivenReaction | CC BY | 34122442 | 20,113,605 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site swelling'. | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | ALDESLEUKIN, MYCOPHENOLIC ACID, PREDNISONE, SIROLIMUS, TACROLIMUS | DrugsGivenReaction | CC BY | 34122442 | 20,113,605 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Squamous cell carcinoma'. | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | MYCOPHENOLIC ACID, PREDNISONE, SIROLIMUS, TACROLIMUS | DrugsGivenReaction | CC BY | 34122442 | 19,803,442 | 2021 |
What was the administration route of drug 'ALDESLEUKIN'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Intralesional | DrugAdministrationRoute | CC BY | 34122442 | 20,113,605 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Oral | DrugAdministrationRoute | CC BY | 34122442 | 19,803,442 | 2021 |
What was the administration route of drug 'SIROLIMUS'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Oral | DrugAdministrationRoute | CC BY | 34122442 | 19,803,442 | 2021 |
What was the administration route of drug 'TACROLIMUS'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Oral | DrugAdministrationRoute | CC BY | 34122442 | 19,803,442 | 2021 |
What was the outcome of reaction 'Disease recurrence'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Recovered | ReactionOutcome | CC BY | 34122442 | 20,068,020 | 2021 |
What was the outcome of reaction 'Squamous cell carcinoma of skin'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Recovered | ReactionOutcome | CC BY | 34122442 | 20,077,962 | 2021 |
What was the outcome of reaction 'Squamous cell carcinoma'? | Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increas... | Recovered | ReactionOutcome | CC BY | 34122442 | 19,803,442 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetic neuropathy'. | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | CYANOCOBALAMIN, GABAPENTIN, GLICLAZIDE, METFORMIN HYDROCHLORIDE, PREGABALIN, RAMIPRIL, VITAMIN D NOS, VITAMINS | DrugsGivenReaction | CC BY | 34122553 | 19,653,762 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | CYANOCOBALAMIN, GABAPENTIN, GLICLAZIDE, METFORMIN HYDROCHLORIDE, PREGABALIN, RAMIPRIL, VITAMIN D NOS, VITAMINS | DrugsGivenReaction | CC BY | 34122553 | 19,653,762 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Duplicate therapy error'. | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | CYANOCOBALAMIN, GABAPENTIN, GLICLAZIDE, METFORMIN HYDROCHLORIDE, PREGABALIN, RAMIPRIL, VITAMIN D NOS, VITAMINS | DrugsGivenReaction | CC BY | 34122553 | 19,653,762 | 2021 |
What was the dosage of drug 'VITAMINS'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | 1 DOSAGE FORM, QD | DrugDosageText | CC BY | 34122553 | 19,653,762 | 2021 |
What was the outcome of reaction 'Ataxia'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovered | ReactionOutcome | CC BY | 34122553 | 19,545,868 | 2021 |
What was the outcome of reaction 'Diabetic neuropathy'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovering | ReactionOutcome | CC BY | 34122553 | 19,653,762 | 2021 |
What was the outcome of reaction 'Disease recurrence'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovering | ReactionOutcome | CC BY | 34122553 | 19,653,762 | 2021 |
What was the outcome of reaction 'Dizziness'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovered | ReactionOutcome | CC BY | 34122553 | 19,545,868 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovered | ReactionOutcome | CC BY | 34122553 | 19,517,192 | 2021 |
What was the outcome of reaction 'Fatigue'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovered | ReactionOutcome | CC BY | 34122553 | 19,545,868 | 2021 |
What was the outcome of reaction 'Product prescribing error'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovered | ReactionOutcome | CC BY | 34122553 | 19,517,192 | 2021 |
What was the outcome of reaction 'Somnolence'? | Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin.
Gabapentinoids comprise the medications gabapentin and pregabalin. These were designed to not only look chemically like the central inhibitory neurotransmitter gamma-aminobutyric acid (GABA) but also act like it. The prototype gabapen... | Recovered | ReactionOutcome | CC BY | 34122553 | 19,545,868 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
Coronavirus 2019 disease (COVID-19) is a deadly disease that was first seen in Wuhan, China, and primarily affects the respiratory system, but also has differ... | ASPIRIN, CYCLOSPORINE, INSULIN GLARGINE, MYCOPHENOLATE MOFETIL, PANTOPRAZOLE, VALSARTAN | DrugsGivenReaction | CC BY | 34122700 | 20,092,970 | 2021 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
Coronavirus 2019 disease (COVID-19) is a deadly disease that was first seen in Wuhan, China, and primarily affects the respiratory system, but also has differ... | Recovered | ReactionOutcome | CC BY | 34122700 | 20,092,970 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Asthma and pulmonary tuberculosis: misdiagnosis or coexistence.
Asthma and pulmonary tuberculosis (PTB) are disease entities with different pathogenesis. However, endobronchial tuberculosis (EBTB), a peculiar form of PTB, can mimic the symptoms of asthma. Although uncommon, the coexistence of asthma and PTB can appear.... | BUDESONIDE\FORMOTEROL | DrugsGivenReaction | CC BY-NC-ND | 34123385 | 20,174,251 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary tuberculosis'. | Asthma and pulmonary tuberculosis: misdiagnosis or coexistence.
Asthma and pulmonary tuberculosis (PTB) are disease entities with different pathogenesis. However, endobronchial tuberculosis (EBTB), a peculiar form of PTB, can mimic the symptoms of asthma. Although uncommon, the coexistence of asthma and PTB can appear.... | BUDESONIDE\FORMOTEROL | DrugsGivenReaction | CC BY-NC-ND | 34123385 | 20,174,324 | 2021-07 |
What was the administration route of drug 'BUDESONIDE\FORMOTEROL'? | Asthma and pulmonary tuberculosis: misdiagnosis or coexistence.
Asthma and pulmonary tuberculosis (PTB) are disease entities with different pathogenesis. However, endobronchial tuberculosis (EBTB), a peculiar form of PTB, can mimic the symptoms of asthma. Although uncommon, the coexistence of asthma and PTB can appear.... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC-ND | 34123385 | 20,158,548 | 2021-07 |
What was the outcome of reaction 'Pulmonary tuberculosis'? | Asthma and pulmonary tuberculosis: misdiagnosis or coexistence.
Asthma and pulmonary tuberculosis (PTB) are disease entities with different pathogenesis. However, endobronchial tuberculosis (EBTB), a peculiar form of PTB, can mimic the symptoms of asthma. Although uncommon, the coexistence of asthma and PTB can appear.... | Recovering | ReactionOutcome | CC BY-NC-ND | 34123385 | 20,174,324 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.
Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresect... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34123437 | 17,131,292 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated thyroiditis'. | Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.
Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresect... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34123437 | 17,131,292 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.
Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresect... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34123437 | 17,131,292 | 2021 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.
Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresect... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34123437 | 17,131,292 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Granuloma annulare'. | Apremilast in the Management of Disseminated Granuloma Annulare.
Granuloma annulare (GA) is a common inflammatory skin condition that manifests as annular skin colored to erythematous papules and plaques. Disseminated GA is a subtype of GA that presents with diffuse cutaneous involvement. While topical and intralesiona... | APREMILAST, ESCITALOPRAM OXALATE, LEVOTHYROXINE | DrugsGivenReaction | CC BY | 34123617 | 19,468,235 | 2021-05-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Apremilast in the Management of Disseminated Granuloma Annulare.
Granuloma annulare (GA) is a common inflammatory skin condition that manifests as annular skin colored to erythematous papules and plaques. Disseminated GA is a subtype of GA that presents with diffuse cutaneous involvement. While topical and intralesiona... | APREMILAST, ESCITALOPRAM OXALATE, LEVOTHYROXINE | DrugsGivenReaction | CC BY | 34123617 | 19,468,235 | 2021-05-09 |
What was the outcome of reaction 'Granuloma annulare'? | Apremilast in the Management of Disseminated Granuloma Annulare.
Granuloma annulare (GA) is a common inflammatory skin condition that manifests as annular skin colored to erythematous papules and plaques. Disseminated GA is a subtype of GA that presents with diffuse cutaneous involvement. While topical and intralesiona... | Recovering | ReactionOutcome | CC BY | 34123617 | 19,468,235 | 2021-05-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aggression'. | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | PERAMPANEL | DrugsGivenReaction | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | PERAMPANEL | DrugsGivenReaction | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | PERAMPANEL | DrugsGivenReaction | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | PERAMPANEL | DrugsGivenReaction | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | PERAMPANEL | DrugsGivenReaction | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicide attempt'. | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | PERAMPANEL | DrugsGivenReaction | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
What was the administration route of drug 'PERAMPANEL'? | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | Oral | DrugAdministrationRoute | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
What was the outcome of reaction 'Aggression'? | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | Recovered | ReactionOutcome | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
What was the outcome of reaction 'Agitation'? | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | Recovered | ReactionOutcome | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
What was the outcome of reaction 'Altered state of consciousness'? | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | Recovered | ReactionOutcome | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
What was the outcome of reaction 'Intentional overdose'? | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | Recovered | ReactionOutcome | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
What was the outcome of reaction 'Suicide attempt'? | "Zombielike" Aggression in Perampanel Overdose.
Perampanel is an antiepileptic drug that blocks amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. To date, little is known about the management of perampanel intoxication. We report a case of "zombielike" behavior secondary to intentional peramp... | Recovered | ReactionOutcome | CC BY | 34123667 | 18,657,299 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | BACLOFEN, OXYCODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | BACLOFEN, OXYCODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Withdrawal syndrome'. | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | BACLOFEN, OXYCODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the administration route of drug 'BACLOFEN'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | Oral | DrugAdministrationRoute | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the dosage of drug 'BACLOFEN'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | 10 mg (milligrams). | DrugDosage | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the dosage of drug 'OXYCODONE HYDROCHLORIDE'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | 10 mg (milligrams). | DrugDosage | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the dosage of drug 'TRAZODONE HYDROCHLORIDE'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | 100 mg (milligrams). | DrugDosage | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the dosage of drug 'ZOLPIDEM TARTRATE'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | 10 mg (milligrams). | DrugDosage | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the outcome of reaction 'Delirium'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | Recovering | ReactionOutcome | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
What was the outcome of reaction 'Withdrawal syndrome'? | Oral Baclofen Withdrawal Resulting in Hyperactive Delirium: A Case Report.
Baclofen is used in the treatment of muscle spasms by acting as an agonist GABAB receptors. Limited case reports describing baclofen withdrawal-induced delirium have largely been demonstrated to occur upon cessation of intrathecal baclofen admin... | Recovering | ReactionOutcome | CC BY | 34123673 | 19,480,901 | 2021-05-12 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.